Rho Ventures

Industry:	Venture Capital & Private Equity
Revenues:	$5 Million
Employees:	40

Description

Rho has been backing venture-stage companies in the U.S. since its inception in 1981. Venture capital funds under management currently exceed $1 billion. Rho Ventures has invested in over 165 venture stage companies and helped build market leaders across many high growth industries. Previous investments include Ciena Corporation, Commerce One, Compaq Computer Corporation, Diversa Corporation, Human Genome Sciences, Inc., iVillage, Leukosite (currently part of Millennium Pharmaceuticals), MedImmune, Inc., NitroMed, Senomyx, Tercica, Tripod (currently part of Lycos), Vanda Pharmaceuticals and Vicuron.

View More Statistics

Site Statistics

Monthly Unique Visitors:	1,539
Site Rank:	776,062
Trust Rating:	Neutral
Stats by

News Archive

RHO Ventures Agrees on $15 Million Growth Equity Investment to Bluefly Wireless News; 12/29/2009 Wireless News 12-29-2009 RHO Ventures Agrees on $15 Million Growth Equity...NewsBluefly, Inc. announced that Rho Ventures has reached a definitive agreement...Company. "We are thrilled to have Rho Ventures as an investor in the business... ...more

RHO Ventures to Make $15 Million Growth Equity Investment in Bluefly. Health & Beauty Close-Up; 12/23/2009 ...fashion trends, announced that Rho Ventures has reached a definitive agreement...Company. "We are thrilled to have Rho Ventures as an investor in the business...completion of the second closing, Rho Ventures will own approximately 33 percent... ...more

RHO Ventures Commits $15 Million Growth Equity Investment to Bluefly. Business Wire; 12/21/2009 ...com), today announced that Rho Ventures has reached a definitive agreement...Company. "We are thrilled to have Rho Ventures as an investor in the business...completion of the second closing, Rho Ventures will own approximately 33% of... ...more